We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANET icon
701
Arista Networks
ANET
$262B
$87.9M 0.01%
3,751,528
+2,443,800
+187% +$67M
GFI icon
702
Gold Fields
GFI
$35.3B
$87.6M 0.01%
9,610,051
-1,421,389
-13% -$17M
ROCK icon
703
Gibraltar Industries
ROCK
$1.47B
$87.6M 0.01%
2,261,280
-549,809
-20% -$22.4M
SRPT icon
704
Sarepta Therapeutics
SRPT
$1.94B
$87.2M 0.01%
1,163,847
+27,042
+2% +$1.99M
TECH icon
705
Bio-Techne
TECH
$11.3B
$87.2M 0.01%
1,006,008
-30,976
-3% -$2.9M
PCH
706
DELISTED
PotlatchDeltic
PCH
$87.1M 0.01%
1,970,027
-1,852
-0.1% -$95.5K
TGT icon
707
Target
TGT
$70.4B
$86.4M 0.01%
611,998
-93,365
-13% -$17.9M
PWR icon
708
Quanta Services
PWR
$102B
$85.5M 0.01%
681,952
-753,146
-52% -$92.4M
GBCI icon
709
Glacier Bancorp
GBCI
$6.47B
$85.4M 0.01%
1,800,648
-45,235
-2% -$2.13M
MGRC icon
710
McGrath RentCorp
MGRC
$2.93B
$84.7M 0.01%
1,114,504
-125,076
-10% -$10.2M
UAL icon
711
United Airlines
UAL
$41.2B
$84.3M 0.01%
2,378,742
+438,872
+23% +$19.3M
BJRI icon
712
BJ's Restaurants
BJRI
$1.43B
$84.1M 0.01%
3,880,400
+94,775
+3% +$2.44M
XHB icon
713
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
$83.3M 0.01%
1,521,973
-1,452
-0.1% -$87.4K
MTX icon
714
Minerals Technologies
MTX
$2.27B
$83M 0.01%
1,353,557
-360,278
-21% -$23M
JRVR icon
715
James River Group Holdings
JRVR
$202M
$82.4M 0.01%
3,325,366
+113,805
+4% +$2.78M
UPWK icon
716
Upwork
UPWK
$1.05B
$82.4M 0.01%
3,984,351
-2,090,883
-34% -$41.1M
FAST icon
717
Fastenal
FAST
$59B
$82M 0.01%
3,286,798
-1,027,254
-24% -$27.7M
KRC icon
718
Kilroy Realty
KRC
$4.3B
$81.9M 0.01%
1,565,965
+194,833
+14% +$12.4M
WOLF icon
719
Wolfspeed
WOLF
$1.66B
$81.6M 0.01%
1,286,602
-459,934
-26% -$38.2M
DCT
720
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$81.5M 0.01%
5,490,598
+36,949
+0.7% +$649K
PLTK icon
721
Playtika
PLTK
$931M
$81.4M 0.01%
6,148,426
-112,672
-2% -$1.75M
RYAN icon
722
Ryan Specialty Holdings
RYAN
$10.8B
$81.2M 0.01%
2,072,078
+539,003
+35% +$20.4M
MXL icon
723
MaxLinear
MXL
$7.06B
$81.2M 0.01%
2,388,692
-144,640
-6% -$6.06M
PRVA icon
724
Privia Health
PRVA
$2.75B
$81M 0.01%
2,780,204
+1,162,270
+72% +$29.5M
WM icon
725
Waste Management
WM
$89.9B
$80.5M 0.01%
526,258
-59,844
-10% -$9.37M

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.